 |
|
Prostate Cancer Screening (PDQ®)
[ patient ] [ health professional ]
Expert-reviewed information summary about tests used to detect or screen for prostate cancer.
Clinical Trials to Screen for Prostate Cancer
Check for prostate cancer screening trials from NCI's PDQ® Cancer Clinical Trials Registry now accepting patients. The list of clinical trials can be refined by location, stage of disease, drug, and other features.
Early Prostate Cancer: Questions and Answers
A fact sheet that describes risk factors for prostate cancer, and symptoms and treatment options for localized disease. Discusses available screening tests. National Cancer Institute Fact Sheet 5.23
Understanding Prostate Changes: A Health Guide for Men
This booklet for men describes changes that may occur in the prostate over time.
Panel Recommends Against PSA Testing in Men 75 or Older
The U.S. Preventive Services Task Force is advising against the routine use of prostate-specific antigen (PSA) testing to screen for prostate cancer in men age 75 and older, according to guidelines published in the August 5, 2008, Annals of Internal Medicine.
The Prostate-Specific Antigen (PSA) Test: Questions and Answers
A fact sheet that describes the PSA screening test for prostate cancer and explains the benefits and limitations of the test. National Cancer Institute Fact Sheet 5.29
Prostate Cancer Research Results From the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Fact Sheet
The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, or PLCO, is a large-scale clinical trial to determine whether certain cancer screening tests reduce deaths from these cancers.
Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
A large-scale clinical trial to determine whether certain cancer screening tests reduce deaths from prostate, lung, colorectal, and ovarian cancer. In addition, there are numerous epidemiologic and ancillary studies going on that will answer other crucial questions about these cancers and these screening tests.
Report from Large NCI Study Suggests PSA Testing Could Be Done at Longer Intervals for Men Who Choose to Test
Many men who choose to get a prostate specific antigen test may not need to repeat the test as frequently as previously thought, according to data from the Prostate, Lung, Colorectal and Ovarian trial.
Protein Patterns in Blood May Predict Prostate Cancer Diagnosis
Patterns of proteins found in patients' blood serum may help distinguish between prostate cancer and benign conditions, scientists from the NCI and FDA report today in the Journal of the National Cancer Institute.
Interpreting Laboratory Test Results
A fact sheet that describes the role of screening and diagnostic laboratory tests. Includes a brief discussion of factors affecting the results. National Cancer Institute Fact Sheet 5.27
Tumor Markers: Questions and Answers
A fact sheet that defines tumor markers and describes how they can be used to aid diagnosis and treatment. National Cancer Institute Fact Sheet 5.18
|
|
|
